PASG vs REGN: Which Stock is Better?
Side-by-side comparison of Passage Bio Inc and Regeneron Pharmaceuticals Inc in 2026
PASG
Passage Bio Inc
$11.67
REGN
Regeneron Pharmaceuticals Inc
$750.57
Key Metrics Comparison
| Metric | PASG | REGN | Winner |
|---|---|---|---|
| Market Cap | $37.44M | $79.35B | REGN |
| P/E Ratio | N/A | 18.08 | REGN |
| EPS (TTM) | $N/A | $41.51 | REGN |
| Revenue Growth | 0.0% | 0.0% | REGN |
| Gross Margin | 0.0% | 44.6% | REGN |
Analyze PASG
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PASG or REGN a better investment?
Comparing PASG and REGN: Passage Bio Inc has a market cap of $37.44M while Regeneron Pharmaceuticals Inc has $79.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PASG and REGN?
PASG (Passage Bio Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PASG or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PASG or REGN?
REGN has higher revenue growth at 0.0% vs 0.0% for PASG.
Which company is more profitable: PASG or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for PASG.
Which is the larger company: PASG or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.35B compared to $37.44M for PASG.
Should I buy PASG or REGN in 2026?
Both PASG and REGN have investment merit. PASG trades at $11.67 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PASG and REGN stock?
Key differences: Market Cap ($37.44M vs $79.35B), P/E Ratio (N/A vs 18.1x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).